Sheffield, B.S.; Banerji, S.; Chankowsky, A.; Dudani, S.; Gill, S.; Gorski, Z.; Kassam, S.; Macaulay, C.; Manna, M.; Perdrizet, K.;
et al. Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada. Curr. Oncol. 2025, 32, 141.
https://doi.org/10.3390/curroncol32030141
AMA Style
Sheffield BS, Banerji S, Chankowsky A, Dudani S, Gill S, Gorski Z, Kassam S, Macaulay C, Manna M, Perdrizet K,
et al. Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada. Current Oncology. 2025; 32(3):141.
https://doi.org/10.3390/curroncol32030141
Chicago/Turabian Style
Sheffield, Brandon S., Shantanu Banerji, Allen Chankowsky, Shaan Dudani, Sharlene Gill, Zuzanna Gorski, Shaqil Kassam, Cassandra Macaulay, Mita Manna, Kirstin Perdrizet,
and et al. 2025. "Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada" Current Oncology 32, no. 3: 141.
https://doi.org/10.3390/curroncol32030141
APA Style
Sheffield, B. S., Banerji, S., Chankowsky, A., Dudani, S., Gill, S., Gorski, Z., Kassam, S., Macaulay, C., Manna, M., Perdrizet, K., Ramjeesingh, R., D’Angelo, M. S., & Servidio-Italiano, F.
(2025). Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada. Current Oncology, 32(3), 141.
https://doi.org/10.3390/curroncol32030141
